A Phase 2, Open-Label Study of the Safety and Efficacy o

Project: Research project

Project Details

Description

A Phase 2, Open-Label Study of the Safety and Efficacy of INCB040093 and INCB040093 Combined With INCB039110 in Subjects With Relapsed or Refractory Hodgkin Lymphoma
StatusFinished
Effective start/end date8/1/158/30/20

Funding

  • Incyte Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.